PUBLISHER: KBV Research | PRODUCT CODE: 1544262
PUBLISHER: KBV Research | PRODUCT CODE: 1544262
Asia Pacific Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Country and Growth Forecast, 2024 - 2031
The Asia Pacific Tuberculosis Diagnostics Market would witness market growth of 5.2% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Tuberculosis Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $312.6 million by 2031. The Japan market is registering a CAGR of 4.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 5.9% during (2024 - 2031).
The market is driven by the need for timely and accurate disease detection, crucial for reducing transmission, initiating effective treatment, and improving patient outcomes. Early diagnosis of TB is essential because it allows for the prompt commencement of treatment, thereby reducing the likelihood of transmission to others and minimizing the risk of complications. This is particularly important in the case of drug-resistant TB, where delays in diagnosis can lead to the spread of more virulent strains that are harder to treat.
Moreover, the market is influenced by a variety of health initiatives and policies that are designed to alleviate the burden of TB, in addition to technological advancements. These initiatives have spurred investment in TB diagnostics from public health agencies and private sector companies, leading to the development of new tools and technologies designed to improve TB detection and management.
In China, the demand for this is rising due to the country's ongoing public health efforts to control TB, particularly in regions with high incidence rates and among vulnerable populations. The Chinese government has prioritized TB detection and treatment, especially in western provinces with less developed healthcare infrastructure. Implementing the National TB Control Program has increased the use of advanced diagnostic methods, including nucleic acid amplification tests (NAATs) and digital radiography, to ensure early and accurate diagnosis. Across the region, there is a clear trend towards adopting innovative diagnostic tools, supported by government initiatives, international funding, and public health campaigns to reduce TB incidence and mortality. Hence, the Asia Pacific region's diverse and dynamic market is poised for continued growth as these nations intensify their efforts to combat TB and expand access to effective diagnostics.
Based on End Use, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Type, the market is segmented into Detection of Latent Infection (Skin Test & IGRA), Phage Assay, Detection of Drug Resistance (DST), Nucleic Acid Testing, Radiographic Method, Cytokine Detection Assay, Diagnostic Laboratory Methods, and Other Methods. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Abbott Laboratories
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Bruker Corporation
- Revvity, Inc.
Asia Pacific Tuberculosis Diagnostics Market Report Segmentation
By End Use
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Type
- Detection of Latent Infection (Skin Test & IGRA)
- Phage Assay
- Detection of Drug Resistance (DST)
- Nucleic Acid Testing
- Radiographic Method
- Cytokine Detection Assay
- Diagnostic Laboratory Methods
- Other Methods
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Tuberculosis Diagnostics Market, by End Use
- 1.4.2 Asia Pacific Tuberculosis Diagnostics Market, by Type
- 1.4.3 Asia Pacific Tuberculosis Diagnostics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Asia Pacific Tuberculosis Diagnostics Market by End Use
- 4.1 Asia Pacific Diagnostic Laboratories Market by Country
- 4.2 Asia Pacific Hospitals & Clinics Market by Country
- 4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Tuberculosis Diagnostics Market by Type
- 5.1 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country
- 5.2 Asia Pacific Phage Assay Market by Country
- 5.3 Asia Pacific Detection of Drug Resistance (DST) Market by Country
- 5.4 Asia Pacific Nucleic Acid Testing Market by Country
- 5.5 Asia Pacific Radiographic Method Market by Country
- 5.6 Asia Pacific Cytokine Detection Assay Market by Country
- 5.7 Asia Pacific Diagnostic Laboratory Methods Market by Country
- 5.8 Asia Pacific Other Methods Market by Country
Chapter 6. Asia Pacific Tuberculosis Diagnostics Market by Country
- 6.1 China Tuberculosis Diagnostics Market
- 6.1.1 China Tuberculosis Diagnostics Market by End Use
- 6.1.2 China Tuberculosis Diagnostics Market by Type
- 6.2 Japan Tuberculosis Diagnostics Market
- 6.2.1 Japan Tuberculosis Diagnostics Market by End Use
- 6.2.2 Japan Tuberculosis Diagnostics Market by Type
- 6.3 India Tuberculosis Diagnostics Market
- 6.3.1 India Tuberculosis Diagnostics Market by End Use
- 6.3.2 India Tuberculosis Diagnostics Market by Type
- 6.4 South Korea Tuberculosis Diagnostics Market
- 6.4.1 South Korea Tuberculosis Diagnostics Market by End Use
- 6.4.2 South Korea Tuberculosis Diagnostics Market by Type
- 6.5 Singapore Tuberculosis Diagnostics Market
- 6.5.1 Singapore Tuberculosis Diagnostics Market by End Use
- 6.5.2 Singapore Tuberculosis Diagnostics Market by Type
- 6.6 Malaysia Tuberculosis Diagnostics Market
- 6.6.1 Malaysia Tuberculosis Diagnostics Market by End Use
- 6.6.2 Malaysia Tuberculosis Diagnostics Market by Type
- 6.7 Rest of Asia Pacific Tuberculosis Diagnostics Market
- 6.7.1 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use
- 6.7.2 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Qiagen N.V.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.2.6 SWOT Analysis
- 7.3 Thermo Fisher Scientific, Inc.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Product Launches and Product Expansions:
- 7.3.6 SWOT Analysis
- 7.4 Becton, Dickinson, and Company
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Partnerships, Collaborations, and Agreements:
- 7.4.6 SWOT Analysis
- 7.5 F. Hoffmann-La Roche Ltd.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Acquisition and Mergers:
- 7.5.6 SWOT Analysis
- 7.6 Hologic, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
- 7.7 Danaher Corporation
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 SWOT Analysis
- 7.8 DiaSorin S.p.A.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.8.5 SWOT Analysis
- 7.9 Bruker Corporation
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.9.5 SWOT Analysis
- 7.10. Revvity, Inc.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 2 Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 3 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 4 Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 5 Asia Pacific Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
- TABLE 6 Asia Pacific Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
- TABLE 7 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
- TABLE 8 Asia Pacific Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
- TABLE 9 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
- TABLE 10 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
- TABLE 11 Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 12 Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 13 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
- TABLE 14 Asia Pacific Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
- TABLE 15 Asia Pacific Phage Assay Market by Country, 2020 - 2023, USD Million
- TABLE 16 Asia Pacific Phage Assay Market by Country, 2024 - 2031, USD Million
- TABLE 17 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
- TABLE 18 Asia Pacific Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
- TABLE 19 Asia Pacific Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
- TABLE 20 Asia Pacific Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
- TABLE 21 Asia Pacific Radiographic Method Market by Country, 2020 - 2023, USD Million
- TABLE 22 Asia Pacific Radiographic Method Market by Country, 2024 - 2031, USD Million
- TABLE 23 Asia Pacific Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
- TABLE 24 Asia Pacific Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
- TABLE 25 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
- TABLE 26 Asia Pacific Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
- TABLE 27 Asia Pacific Other Methods Market by Country, 2020 - 2023, USD Million
- TABLE 28 Asia Pacific Other Methods Market by Country, 2024 - 2031, USD Million
- TABLE 29 Asia Pacific Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
- TABLE 30 Asia Pacific Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
- TABLE 31 China Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 32 China Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 33 China Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 34 China Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 35 China Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 36 China Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 37 Japan Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 38 Japan Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 39 Japan Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 40 Japan Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 41 Japan Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 42 Japan Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 43 India Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 44 India Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 45 India Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 46 India Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 47 India Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 48 India Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 49 South Korea Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 50 South Korea Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 51 South Korea Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 52 South Korea Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 53 South Korea Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 54 South Korea Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 55 Singapore Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 56 Singapore Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 57 Singapore Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 58 Singapore Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 59 Singapore Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 60 Singapore Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 61 Malaysia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 62 Malaysia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 63 Malaysia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 64 Malaysia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 65 Malaysia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 66 Malaysia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 67 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
- TABLE 68 Rest of Asia Pacific Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
- TABLE 69 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
- TABLE 70 Rest of Asia Pacific Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
- TABLE 71 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
- TABLE 72 Rest of Asia Pacific Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
- TABLE 73 Key Information - Abbott Laboratories
- TABLE 74 Key Information - Qiagen N.V.
- TABLE 75 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 76 Key Information - Becton, Dickinson and Company
- TABLE 77 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 78 Key Information - Hologic, Inc.
- TABLE 79 Key Information - Danaher Corporation
- TABLE 80 Key Information - DiaSorin S.p.A.
- TABLE 81 Key Information - Bruker Corporation
- TABLE 82 Key Information - Revvity, Inc.
